Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Zimmer Biomet (ZBH)

Zimmer Biomet: Named Executive Mark Bezjak to Resign Effective January 16, 2026

Neutral Impact 2 of 5 leadership Written later

Zimmer Biomet said Mark Bezjak, a named executive officer in its 2025 proxy statement, informed the company on January 8, 2026 that he will resign his employment and all officer positions effective January 16, 2026, to pursue another business opportunity. The filing notes he already ceased to be an executive officer on July 1, 2025, so the change is largely a formal exit. The filing does not name a successor.

Key points

  • Mark Bezjak notified the company on January 8, 2026 of his resignation.
  • Resignation takes effect January 16, 2026, covering his employment and all officer roles at the company and its affiliates.
  • Bezjak stopped being an executive officer on July 1, 2025, as previously reported.
  • The filing reports no financial results; its only exhibit is the Inline XBRL cover page file.

The filing

CompanyZimmer Biomet (ZBH)
Form8-K, current report
Filed with the SECJan 12, 2026, 9:00 AM ET
Accession number0001193125-26-009895

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.